Iris involvement in natural killer/T-cell lymphoma

Jpn J Ophthalmol. 2006 Nov-Dec;50(6):557-558. doi: 10.1007/s10384-006-0363-8.

Authors

Yuka Shimonagano¹, Kumiko Nakao², Taiji Sakamoto¹, Kimiharu Uozumi³, Koichi Haraguchi³

Affiliations

¹ Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
² Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. nakao@m2.kufm.kagoshima-u.ac.jp.
³ Division of Host Response, Center for Chronic Viral Disease, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

PMID: 17180534
DOI: 10.1007/s10384-006-0363-8

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / therapeutic use
Biomarkers, Tumor / analysis
Humans
Iris Neoplasms / chemistry
Iris Neoplasms / drug therapy
Iris Neoplasms / pathology*
Killer Cells, Natural / chemistry
Killer Cells, Natural / drug effects
Killer Cells, Natural / pathology*
Lymphoma, T-Cell / chemistry
Lymphoma, T-Cell / drug therapy
Lymphoma, T-Cell / pathology*
Male
Middle Aged
Visual Acuity

Substances

Antineoplastic Agents
Biomarkers, Tumor